These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 5467751)

  • 21. An examination of central actions characteristic of scopolamine: comparison of central and peripheral activity in scopolamine, atropine and some synthetic basic esters.
    Aparkes MW
    Psychopharmacologia; 1965 Jan; 7(1):1-19. PubMed ID: 5830966
    [No Abstract]   [Full Text] [Related]  

  • 22. Morphine tolerance and physical dependence: influence of cholinergic agonists and antagonists.
    Bhargava HN; Way EL
    Eur J Pharmacol; 1976 Mar; 36(1):79-88. PubMed ID: 944135
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Modulation of cholinergic activity and the aversive threshold in the rat.
    Houser VP; Van Hart DA
    Pharmacol Biochem Behav; 1974; 2(5):631-7. PubMed ID: 4431827
    [No Abstract]   [Full Text] [Related]  

  • 24. Interaction of cholinergic and dopaminergic influences on yawning behavior.
    Holmgren B; Urbá-Holmgren R
    Acta Neurobiol Exp (Wars); 1980; 40(3):633-42. PubMed ID: 6969021
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interactions of drugs acting on central dopamine receptors and cholinoceptors on yawning responses in the rat induced by apomorphine, bromocriptine or physostigmine.
    Zarrindast MR; Poursoltan M
    Br J Pharmacol; 1989 Apr; 96(4):843-8. PubMed ID: 2663110
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relationship of the behavioral effects of aprophen, atropine and scopolamine to antagonism of the behavioral effects of physostigmine.
    Genovese RF; Elsmore TF; Witkin JM
    Pharmacol Biochem Behav; 1990 Sep; 37(1):117-22. PubMed ID: 2263653
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of apomorphine-induced climbing in mice by cholinergic drugs and neuroleptics.
    Lassen JB
    Acta Pharmacol Toxicol (Copenh); 1979 Aug; 45(2):161-5. PubMed ID: 40391
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of selective central muscarinic blockade on schedule-controlled behavior and on the rate-decreasing effects of physostigmine.
    Hymowitz N; Brezenoff HE
    Pharmacol Biochem Behav; 1984 Jul; 21(1):109-15. PubMed ID: 6463084
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Inhibitory activities of several atropine-like drugs on the contraction of the digestive system and urinary bladder induced by the parasympathetic nerve stimulation in the dog].
    Kumada S; Otsuka M
    Nihon Yakurigaku Zasshi; 1970 Sep; 66(5):600-5. PubMed ID: 5529897
    [No Abstract]   [Full Text] [Related]  

  • 30. A comparison of antagonists of physostigmine-induced suppression of behavior.
    Vaillant GE
    J Pharmacol Exp Ther; 1967 Sep; 157(3):636-48. PubMed ID: 4963332
    [No Abstract]   [Full Text] [Related]  

  • 31. [The antiataxic mechanism of TRH in rolling mouse Nagoya: the effects of pretreatment with dopaminergic and cholinergic drugs].
    Matsui K; Ando K
    Jikken Dobutsu; 1984 Oct; 33(4):465-9. PubMed ID: 6440800
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Antimuscarinic action of parkinsonism drugs on peripheral structures and correlation with central efficacy or clinical dosage].
    Oelszner W; Walther H; Wagner U
    Acta Biol Med Ger; 1971; 26(5):1045-59. PubMed ID: 5145608
    [No Abstract]   [Full Text] [Related]  

  • 33. [Stereotypy following amphetamine and apomorphine and its influencing by drugs].
    Menge HG; Brand U
    Psychopharmacologia; 1971; 21(3):212-28. PubMed ID: 5095412
    [No Abstract]   [Full Text] [Related]  

  • 34. Central and peripheral anticholinergic potency of some drugs antagonistic to anticholinesterase poisoning.
    Madill HD; Stewart WC; Savoie ML
    Can J Physiol Pharmacol; 1968 Jul; 46(4):559-65. PubMed ID: 5668200
    [No Abstract]   [Full Text] [Related]  

  • 35. Dopaminergic supersensitivity: influence of dopamine agonists, cholinergics, anticholinergics, and drugs used for the treatment of tardive dyskinesia.
    Christensen AV; Nielsen IM
    Psychopharmacology (Berl); 1979 Apr; 62(2):111-6. PubMed ID: 111273
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cholinergic drug effects on antidepressant-induced behaviour in the forced swimming test.
    Mancinelli A; Borsini F; d'Aranno V; Lecci A; Meli A
    Eur J Pharmacol; 1988 Dec; 158(3):199-205. PubMed ID: 3253098
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The actions of atropine, tropenziline and N-butyl hyoscine bromide on the isolated distal colon of the guinea-pig: a comparison of their activities and mechanisms of action.
    Lecchini S; Del Tacca M; Soldani G; Frigg GM; Crema A
    J Pharm Pharmacol; 1969 Oct; 21(10):662-7. PubMed ID: 4390607
    [No Abstract]   [Full Text] [Related]  

  • 38. Effects of intrastriatal injections of atropine and methacholine on the apomorphine-induced gnawing in the rabbit.
    Wolfarth S; Kolasiewicz W
    Pharmacol Biochem Behav; 1977 Jan; 6(1):5-10. PubMed ID: 557798
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of azaprophen, scopolamine and trihexyphenidyl on schedule-controlled behavior, before and after chronic physostigmine.
    Genovese RF
    Eur J Pharmacol; 1990 Feb; 176(3):271-9. PubMed ID: 2328755
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of cholinergic mechanisms in states of wakefulness and sleep.
    Domino EF; Yamamoto K; Dren AT
    Prog Brain Res; 1968; 28():113-33. PubMed ID: 5749010
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.